NVWM LLC’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.55K Hold
32
﹤0.01% 551
2026
Q1
$1.16K Hold
32
﹤0.01% 555
2025
Q4
$1.61K Buy
32
+1
+3% +$51 ﹤0.01% 507
2025
Q3
$1.76K Hold
31
﹤0.01% 461
2025
Q2
$2.17K Hold
31
﹤0.01% 412
2025
Q1
$2.15K Sell
31
-317
-91% -$26.2K ﹤0.01% 387
2024
Q4
$29.9K Sell
348
-11,447
-97% -$1.24M 0.01% 253
2024
Q3
$1.4M Buy
11,795
+131
+1% +$17.5K 0.36% 83
2024
Q2
$1.66M Buy
11,664
+7,599
+187% +$1.01M 0.44% 58
2024
Q1
$522K Buy
+4,065
New +$484K 0.14% 166

Other funds holding NVO

NVWM LLC's NVO Position: Q2 2026 in Review

NVWM LLC held its Novo Nordisk (NVO) position steady in Q2 2026 at 32 shares worth $1.55K. The position accounts for ﹤0.01% of the portfolio, ranked #551.

NVWM LLC first reported a position in NVO in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.66M in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • NVWM LLC held 32 shares of Novo Nordisk worth $1.55K as of Q2 2026.
  • NVWM LLC left its Novo Nordisk share count unchanged in Q2 2026.
  • Novo Nordisk made up ﹤0.01% of NVWM LLC's portfolio in Q2 2026, its #551 holding.
  • NVWM LLC first reported a position in Novo Nordisk in Q1 2024 and has held it in 10 quarters since.
  • NVWM LLC's Novo Nordisk position peaked at $1.66M in Q2 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on NVWM LLC's 13F filing for Q2 2026, filed 29 Jul 2026.